Acute cardiac care & resuscitation

Norepinephrine Equivalent Dose for Mortality Risk Stratification in Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO) Cardiogenic Shock

JACC AdvPublished bicentric retrospective study

Authors' conclusion

In VA-ECMO-supported CS with vasoplegia, vasopressor burden shows a linear relationship with mortality. A NEE threshold of 0.443 μg·kg-1·min-1 may identify patients with elevated mortality risk.

Study context

Population
Patients with cardiogenic shock (CS) requiring VA-ECMOconsecutive patients with CS requiring VA-ECMO
Participants
572 patients
Exposure
High vs lower vasopressor burden by NEE threshold of 0.443 μg·kg-1·min-1
Outcome
NEE at ECMO initiation
Follow-up
ECMO initiation
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Median NEE

0.30 (IQR: 0.09-0.72) μg·kg-1·min-1

Received norepinephrine

86.2%

Observational data: associations, not effects.

Further findings

OutcomeLower vasopressor burdenEstimateP value
Mortality, per NEE incrementLinear dose-responseHR 1.06 (95% CI 1.04–1.08)P < 0.001
30-day mortality · 30 daysHigh vasopressor burden (NEE ≥0.443 μg·kg-1·min-1)vs Lower vasopressor burdenUnadjusted mortality comparison P < 0.00142.6%adjusted HR 1.42 (95% CI 1.11–1.81)P = 0.005
Factors associated with high vasopressor burdenBaseline lactate · multivariable logistic regressionOR 1.05 per mmol/L (95% CI 1.01–1.09)
Factors associated with high vasopressor burdenSurvival After Veno-Arterial ECMO score · lower score associated with high burden · multivariable logistic regressionOR 0.96 per point (95% CI 0.92–1.00)

Factors associated with high vasopressor burden

OR (95% CI)
Mechanical ventilationMultivariable logistic regression2.96 (1.08–8.07)
Prior epinephrine useMultivariable logistic regression1.87 (1.12–3.14)
Renal replacement therapy before VA-ECMOMultivariable logistic regression1.76 (1.02–3.03)
Left ventricular unloadingInversely associated · multivariable logistic regression0.54 (0.34–0.87)
  • 30-day mortality: High vasopressor burden (NEE ≥0.443 μg·kg-1·min-1) 61.8%

Original publication

Norepinephrine Equivalent Dose for Mortality Risk Stratification in VA-ECMO Cardiogenic Shock. JACC Adv. Published October 2026. doi:10.1016/j.jacadv.2026.103208

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.